Literature DB >> 7840433

Nephelometric measurements of human IgG subclasses and their reference ranges.

A Vlug1, E J Nieuwenhuys, R V van Eijk, H G Geertzen, A J van Houte.   

Abstract

IgG subclass measurements are generally performed with the radial immunodiffusion (RID) technique. With this method, results are obtained after an incubation period of 48-72 hours. We developed nephelometric assays on the Behring Nephelometer Analyzer (BNA) that allow a quantification of IgG subclass concentrations in a large number of samples quickly (less than 15 minutes for a complete IgG subclass profile) and reproducibly (intra-assay variation 2.5-5.5%, interassay variation 3.4-6.0% and inter-lab variation 5.4-10.3%). The nephelometric method was compared with the RID technique by analyzing the IgG subclass levels in sixty selected samples. For all IgG subclasses identical results and high correlation coefficients (r > 0.93) were found. In addition, the detection limits of the nephelometric method for all four IgG subclasses were identical or lower than those of the RID technique. Furthermore, the interlab variations of the nephelometric IgG subclass assays are lower than those of the RID method. However, the major advantages of the nephelometric assay are the speed, the minimal workload (automated IgG subclass determinations) and the possibility for automated bidirectional data transmission. Recently we have established new reference ranges for the human IgG subclasses in sera of adults and children. In order to validate these reference values we have measured the IgG subclasses in sera from 112 healthy children with the nephelometric method. In 1992, more than 2000 patient sera were tested by the nephelometric assay. A predominance of IgG2 abnormality was observed. In 9.8% of these sera the IgG2 concentration was decreased. Elevated IgG2 concentrations were found in 1.9% of the sera. Furthermore, the sum of the quantitated four IgG subclasses was similar to that of total IgG (less than 20% difference).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7840433

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  22 in total

1.  B and T cell immunity in patients with lysinuric protein intolerance.

Authors:  M Lukkarinen; K Parto; O Ruuskanen; O Vainio; H Käyhty; R M Olander; O Simell
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Flebogamma 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy.

Authors:  J I Jorquera
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

3.  Clinical and immunological evaluation of patients with mild IgG1 deficiency.

Authors:  D A Van Kessel; P E Horikx; A J Van Houte; C S De Graaff; H Van Velzen-Blad; G T Rijkers
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  Persistent changes in circulating white blood cell populations after splenectomy.

Authors:  Minke A E Rab; Aafke Meerveld-Eggink; Heleen van Velzen-Blad; Douwe van Loon; Ger T Rijkers; Okke de Weerdt
Journal:  Int J Hematol       Date:  2017-09-26       Impact factor: 2.490

5.  Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis.

Authors:  Bjarne Vincents; Arndt Guentsch; Dominika Kostolowska; Ulrich von Pawel-Rammingen; Sigrun Eick; Jan Potempa; Magnus Abrahamson
Journal:  FASEB J       Date:  2011-07-18       Impact factor: 5.191

6.  Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiency.

Authors:  Melvin Berger; Paul J Pinciaro; Arthur Althaus; Mark Ballow; Akhilesh Chouksey; James Moy; Hans Ochs; Mark Stein
Journal:  J Clin Immunol       Date:  2009-12-08       Impact factor: 8.317

7.  Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis.

Authors:  L G Pelkmans; T R Hendriksz; P J Westenend; H J Vermeer; E F H van Bommel
Journal:  Clin Rheumatol       Date:  2017-01-19       Impact factor: 2.980

8.  Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections.

Authors:  D A van Kessel; T W Hoffman; H van Velzen-Blad; P Zanen; G T Rijkers; J C Grutters
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

9.  Pediatric reference intervals for soluble transferrin receptor and transferrin receptor-ferritin index.

Authors:  Cara Lianne Ooi; Nathalie Lepage; Ed Nieuwenhuys; Ajay Parkash Sharma; Guido Filler
Journal:  World J Pediatr       Date:  2009-07-09       Impact factor: 2.764

10.  Expansion of HIV-specific T follicular helper cells in chronic HIV infection.

Authors:  Madelene Lindqvist; Jan van Lunzen; Damien Z Soghoian; Bjorn D Kuhl; Srinika Ranasinghe; Gregory Kranias; Michael D Flanders; Samuel Cutler; Naomi Yudanin; Matthias I Muller; Isaiah Davis; Donna Farber; Philip Hartjen; Friedrich Haag; Galit Alter; Julian Schulze zur Wiesch; Hendrik Streeck
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.